{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:20:27Z","timestamp":1794565227017,"version":"4.9.1"},"reference-count":83,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:sec id=\"ab-hrv210006-1\"><jats:title>Importance<\/jats:title><jats:p>A growing body of evidence suggests that adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy, gestational diabetes (GD), preterm birth, and intrauterine growth restriction, are associated with increased risk of cardiometabolic disease and cardiovascular disease (CVD) later in life. Adverse pregnancy outcomes may therefore represent an opportunity to intervene to prevent or delay onset of CVD. The objective of this review was to summarize the current evidence for targeted postpartum interventions and strategies to reduce CVD risk in women with a history of APOs.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hrv210006-2\"><jats:title>Observations<\/jats:title><jats:p>A search of PubMed and Ovid for English-language randomized clinical trials, cohort studies, descriptive studies, and guidelines published from January 1, 2000, to April 30, 2021, was performed. Four broad categories of interventions were identified: transitional clinics, lifestyle interventions, pharmacotherapy, and patient and clinician education. Observational studies suggest that postpartum transitional clinics identify women who are at elevated risk for CVD and may aid in the transition to longitudinal primary care. Lifestyle interventions to increase physical activity and improve diet quality may help reduce the incidence of type 2 diabetes in women with prior GD; less is known about women with other prior APOs. Metformin hydrochloride may prevent development of type 2 diabetes in women with prior GD. Evidence is lacking in regard to specific pharmacotherapies after other APOs. Cardiovascular guidelines endorse using a history of APOs to refine CVD risk assessment and guide statin prescription for primary prevention in women with intermediate calculated 10-year CVD risk. Research suggests a low level of awareness of the link between APOs and CVD among both patients and clinicians.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hrv210006-3\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>These findings suggest that transitional clinics, lifestyle intervention, targeted pharmacotherapy, and clinician and patient education represent promising strategies for improving postpartum maternal cardiometabolic health in women with APOs; further research is needed to develop and rigorously evaluate these interventions. Future efforts should focus on strategies to increase maternal postpartum follow-up, improve accessibility to interventions across diverse racial and cultural groups, expand awareness of sex-specific CVD risk factors, and define evidence-based precision prevention strategies for this high-risk population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2021.4391","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T15:33:45Z","timestamp":1635348825000},"page":"346","source":"Crossref","is-referenced-by-count":109,"title":["Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes"],"prefix":"10.1001","volume":"7","author":[{"given":"Amanda R.","family":"Jowell","sequence":"first","affiliation":[{"name":"Currently a medical student at Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy A.","family":"Sarma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Corrigan Women\u2019s Heart Health Program, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[{"name":"Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Vaught","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Surgical Critical Care, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille E.","family":"Powe","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Diabetes Unit, Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Honigberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Corrigan Women\u2019s Heart Health Program, Massachusetts General Hospital, Boston"},{"name":"Program in Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"hrv210006r1","doi-asserted-by":"publisher","first-page":"484.e1","DOI":"10.1016\/j.ajog.2016.05.047","article-title":"Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes.","volume":"215","author":"Cain","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"hrv210006r2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/heartjnl-2017-312299","article-title":"Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.","volume":"104","author":"Jarvie","year":"2018","journal-title":"Heart"},{"issue":"3","key":"hrv210006r3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/obr.v19.3","article-title":"Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women.","volume":"19","author":"Song","year":"2018","journal-title":"Obes Rev"},{"issue":"May","key":"hrv210006r4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.preghy.2020.05.015","article-title":"Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.","volume":"21","author":"Rosenbloom","year":"2020","journal-title":"Pregnancy Hypertens"},{"issue":"8","key":"hrv210006r5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications.","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"issue":"22","key":"hrv210006r6","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","article-title":"Long-term cardiovascular risk in women with hypertension during pregnancy.","volume":"74","author":"Honigberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hrv210006r7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jamainternmed.2017.2790","article-title":"Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women.","volume":"177","author":"Tobias","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"18","key":"hrv210006r8","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","article-title":"Incidence and long-term outcomes of hypertensive disorders of pregnancy.","volume":"75","author":"Garovic","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"hrv210006r9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diabres.2018.05.010","article-title":"Prevalence of gestational diabetes and subsequent type 2 diabetes among US women.","volume":"141","author":"Casagrande","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"hrv210006r10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1161\/CIRCULATIONAHA.116.025954","article-title":"Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women.","volume":"135","author":"Tanz","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"hrv210006r11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s13669-013-0041-z","article-title":"Intrauterine growth restriction (IUGR): etiology and diagnosis.","volume":"2","author":"Suhag","year":"2013","journal-title":"Curr Obstet Gynecol Rep"},{"key":"hrv210006r12","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: a public health perspective.","volume":"30","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"hrv210006r13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-00000009","article-title":"Ethnic and racial disparities in the risk of preterm birth: a systematic review and meta-analysis.","volume":"30","author":"Schaaf","year":"2013","journal-title":"Am J Perinatol"},{"issue":"4","key":"hrv210006r14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M17-2740","article-title":"Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study.","volume":"169","author":"Stuart","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"hrv210006r15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/jwh.2018.7150","article-title":"Preterm delivery and maternal cardiovascular disease risk factors: the Nurses\u2019 Health Study II.","volume":"28","author":"Tanz","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"9","key":"hrv210006r16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S1701-2163(16)35382-8","article-title":"Risk estimation of metabolic syndrome at one and three years after a pregnancy complicated by preeclampsia.","volume":"34","author":"Smith","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"hrv210006r17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jacc.2020.04.072","article-title":"Pre-term delivery and risk of ischemic heart disease in women.","volume":"76","author":"Crump","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hrv210006r18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamacardio.2020.4097","article-title":"Association of adverse pregnancy outcomes with risk of atherosclerotic cardiovascular disease in postmenopausal women.","volume":"5","author":"S\u00f8ndergaard","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"11","key":"hrv210006r19","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"7491","key":"hrv210006r20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"issue":"7","key":"hrv210006r21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/CIRCULATIONAHA.120.047936","article-title":"Genetic variation in cardiometabolic traits and medication targets and the risk of hypertensive disorders of pregnancy.","volume":"142","author":"Honigberg","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"hrv210006r22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/bjo.v128.1","article-title":"Risk of pre-eclampsia in patients with a maternal genetic predisposition to common medical conditions: a case-control study.","volume":"128","author":"Gray","year":"2021","journal-title":"BJOG"},{"issue":"12","key":"hrv210006r23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11892-020-01355-3","article-title":"Genetic studies of gestational diabetes and glucose metabolism in pregnancy.","volume":"20","author":"Powe","year":"2020","journal-title":"Curr Diab Rep"},{"issue":"16","key":"hrv210006r24","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.jacc.2018.12.092","article-title":"Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week.","volume":"73","author":"Lane-Cordova","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"hrv210006r25","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1161\/CIR.0000000000000961","article-title":"Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women.","volume":"143","author":"Parikh","year":"2021","journal-title":"Circulation"},{"issue":"736","key":"hrv210006r27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/AOG.0000000000002633","article-title":"ACOG Committee opinion No. 736: optimizing postpartum care.","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"hrv210006r28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/AOG.0000000000003243","article-title":"ACOG practice bulletin No 212: pregnancy and heart disease.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"hrv210006r29","doi-asserted-by":"publisher","first-page":"438.e1","DOI":"10.1016\/j.ajog.2013.12.001","article-title":"The Maternal Health Clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications.","volume":"210","author":"Cusimano","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"hrv210006r30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cjca.2019.03.008","article-title":"Referral to cardiology following postpartum cardiovascular risk screening at the Maternal Health Clinic in Kingston, Ontario.","volume":"35","author":"Gladstone","year":"2019","journal-title":"Can J Cardiol"},{"issue":"4","key":"hrv210006r31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S1701-2163(15)30283-8","article-title":"Cardiovascular risk reduction and weight management at a hospital-based postpartum preeclampsia clinic.","volume":"37","author":"Janmohamed","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"issue":"11","key":"hrv210006r32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10995-019-02768-7","article-title":"Caring for women after hypertensive pregnancies and beyond: implementation and integration of a postpartum transition clinic.","volume":"23","author":"Celi","year":"2019","journal-title":"Matern Child Health J"},{"issue":"6","key":"hrv210006r33","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/AOG.0000000000000856","article-title":"Recognition by women\u2019s health care providers of long-term cardiovascular disease risk after preeclampsia.","volume":"125","author":"Wilkins-Haug","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"hrv210006r34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000445","article-title":"Follow-up after gestational diabetes: a fixable gap in women\u2019s preventive healthcare.","volume":"5","author":"Bernstein","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"17","key":"hrv210006r35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016357","article-title":"Patterns of postpartum ambulatory care follow-up care among women with hypertensive disorders of pregnancy.","volume":"9","author":"Lewey","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"hrv210006r36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s11606-013-2744-2","article-title":"Utilization of primary and obstetric care after medically complicated pregnancies: an analysis of medical claims data.","volume":"29","author":"Bennett","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"12","key":"hrv210006r37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/jp.2016.137","article-title":"Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia.","volume":"36","author":"Levine","year":"2016","journal-title":"J Perinatol"},{"issue":"2","key":"hrv210006r38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/HYPERTENSIONAHA.118.10911","article-title":"Self-management of postnatal hypertension: the SNAP-HT trial.","volume":"72","author":"Cairns","year":"2018","journal-title":"Hypertension"},{"key":"hrv210006r39","doi-asserted-by":"publisher","first-page":"j3024","DOI":"10.1136\/bmj.j3024","article-title":"Lifestyle in progression from hypertensive disorders of pregnancy to chronic hypertension in Nurses\u2019 Health Study II: observational cohort study.","volume":"358","author":"Timpka","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"hrv210006r40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamainternmed.2014.1795","article-title":"Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study.","volume":"174","author":"Bao","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"5","key":"hrv210006r41","doi-asserted-by":"publisher","first-page":"516.e1","DOI":"10.1016\/j.ajog.2014.04.025","article-title":"Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects.","volume":"211","author":"Scholten","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"hrv210006r42","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1089\/jwh.2018.7523","article-title":"Randomized trial to reduce cardiovascular risk in women with recent preeclampsia.","volume":"28","author":"Rich-Edwards","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"hrv210006r43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clnesp.2019.10.011","article-title":"Systematic review of effectiveness and cost-effectiveness of lifestyle interventions to improve clinical diabetes outcome measures in women with a history of GDM.","volume":"35","author":"Hewage","year":"2020","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"hrv210006r44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/jwh.2015.5262","article-title":"Postpartum lifestyle interventions to prevent type 2 diabetes among women with history of gestational diabetes: a systematic review of randomized clinical trials.","volume":"25","author":"Guo","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"hrv210006r45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fendo.2018.00583","article-title":"Lifestyle intervention for the prevention of diabetes in women with previous gestational diabetes mellitus: a systematic review and meta-analysis.","volume":"9","author":"Goveia","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"hrv210006r46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pcd.2017.05.002","article-title":"How to prevent type 2 diabetes in women with previous gestational diabetes? a systematic review of behavioural interventions.","volume":"11","author":"Pedersen","year":"2017","journal-title":"Prim Care Diabetes"},{"key":"hrv210006r47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.pmedr.2015.05.009","article-title":"Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes.","volume":"2","author":"Gilinsky","year":"2015","journal-title":"Prev Med Rep"},{"issue":"12","key":"hrv210006r48","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.","volume":"93","author":"Ratner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"hrv210006r49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"hrv210006r50","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/jc.2014-3761","article-title":"The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program Outcomes Study 10-year follow-up.","volume":"100","author":"Aroda","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"hrv210006r51","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.2337\/dc21-S014","article-title":"14. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes-2021.","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"hrv210006r52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/AOG.0000000000000420","article-title":"A web-based lifestyle intervention for women with recent gestational diabetes mellitus: a randomized controlled trial.","volume":"124","author":"Nicklas","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"hrv210006r53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/dc15-1254","article-title":"The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the Gestational Diabetes\u2019 Effects on Moms (GEM) cluster randomized controlled trial.","volume":"39","author":"Ferrara","year":"2016","journal-title":"Diabetes Care"},{"issue":"7","key":"hrv210006r54","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1210\/jc.2017-02654","article-title":"Postnatal lifestyle intervention for overweight women with previous gestational diabetes: a randomized controlled trial.","volume":"103","author":"Holmes","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"hrv210006r55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/10641955.2016.1154967","article-title":"Improving the postpartum care of women with a recent history of preeclampsia: a focus group study.","volume":"35","author":"Skurnik","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"hrv210006r56","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1471-2393-13-240","article-title":"Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study.","volume":"13","author":"Seely","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"hrv210006r57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2393-11-23","article-title":"Identifying postpartum intervention approaches to prevent type 2 diabetes in women with a history of gestational diabetes.","volume":"11","author":"Nicklas","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"hrv210006r58","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/01.AOG.0000346884.67796.ca","article-title":"Duration of lactation and risk factors for maternal cardiovascular disease.","volume":"113","author":"Schwarz","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"6","key":"hrv210006r59","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/jdi.2018.9.issue-6","article-title":"Lactation and progression to type 2 diabetes in patients with gestational diabetes mellitus: a systematic review and meta-analysis of cohort studies.","volume":"9","author":"Feng","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"12","key":"hrv210006r60","doi-asserted-by":"publisher","first-page":"889","DOI":"10.7326\/M15-0807","article-title":"Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus\u2014a prospective cohort study.","volume":"163","author":"Gunderson","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"hrv210006r70","first-page":"1","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia.","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"11","key":"hrv210006r71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018696","article-title":"Postpartum management of hypertensive disorders of pregnancy: a systematic review.","volume":"7","author":"Cairns","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"hrv210006r72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107548","article-title":"Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight\/obese women with recent gestational diabetes: a double-blind, randomized, placebo-controlled study.","volume":"34","author":"Elkind-Hirsch","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"3","key":"hrv210006r73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100139","article-title":"A randomized trial of dapagliflozin and metformin, alone and combined, in overweight women after gestational diabetes mellitus.","volume":"2","author":"Elkind-Hirsch","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"4","key":"hrv210006r74","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4158\/EP-2017-0251","article-title":"Short-term sitagliptin-metformin therapy is more effective than metformin or placebo in prior gestational diabetic women with impaired glucose regulation.","volume":"24","author":"Elkind-Hirsch","year":"2018","journal-title":"Endocr Pract"},{"key":"hrv210006r75","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fcvm.2019.00178","article-title":"Assessing knowledge gaps of women and healthcare providers concerning cardiovascular risk after hypertensive disorders of pregnancy: a scoping review.","volume":"6","author":"Roth","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"hrv210006r76","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10641955.2010.544955","article-title":"Physicians\u2019 knowledge of future vascular disease in women with preeclampsia.","volume":"31","author":"Young","year":"2012","journal-title":"Hypertens Pregnancy"},{"issue":"9","key":"hrv210006r77","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1089\/jwh.2019.7767","article-title":"Provider counseling about and risk perception for future chronic disease among women with gestational diabetes and preeclampsia.","volume":"29","author":"Sutherland","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"hrv210006r78","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1353\/hpu.0.0355","article-title":"Familias Sanas: an intervention designed to increase rates of postpartum visits among Latinas.","volume":"21","author":"Marsiglia","year":"2010","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"hrv210006r79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s13142-014-0253-4","article-title":"Dulce Mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes.","volume":"4","author":"Philis-Tsimikas","year":"2014","journal-title":"Transl Behav Med"},{"issue":"18","key":"hrv210006r80","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2020.01.064","article-title":"Women\u2019s cardiovascular health after hypertensive pregnancy: the long view from labor and delivery becomes clearer.","volume":"75","author":"Honigberg","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hrv210006r81","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jacc.2018.05.077","article-title":"Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction.","volume":"72","author":"Stuart","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hrv210006r82","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/eurheartj\/ehy863","article-title":"Does pregnancy complication history improve cardiovascular disease risk prediction? findings from the HUNT study in Norway.","volume":"40","author":"Markovitz","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"hrv210006r83","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015569","article-title":"Improving cardiovascular workforce competencies in cardio-obstetrics: current challenges and future directions.","volume":"9","author":"Sharma","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"hrv210006r26","unstructured":"Centers for Disease Control and prevention (CDC).  Pregnancy Mortality Surveillance System: trends in pregnancy-related deaths. Updated November 25, 2020. Accessed March 1, 2021. https:\/\/www.cdc.gov\/reproductivehealth\/maternal-mortality\/pregnancy-mortality-surveillance-system.htm#"},{"key":"hrv210006r61","unstructured":"Heart Health 4 New Moms: a randomized trial in the first year after preeclampsia (HH4NM). ClinicalTrials.gov identifier: NCT03749746. Updated December 3, 2020. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03749746"},{"key":"hrv210006r62","unstructured":"Virtual cardiac wellness program following hypertensive disorders of pregnancy. ClinicalTrials.gov identifier: NCT04998942. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04998942"},{"key":"hrv210006r63","unstructured":"Lifestyle intervention for women with recent pre-eclampsia or gestational diabetes mellitus (\u201cMom's Healthy Heart\u201d). ClinicalTrials.gov identifier: NCT03993145. Updated May 12, 2021. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03993145"},{"key":"hrv210006r64","unstructured":"Fit After Baby: increasing postpartum weight loss in women at increased risk for cardiometabolic disease (FAB). ClinicalTrials.gov identifier: NCT03215173. Updated March 8, 2021. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03215173"},{"key":"hrv210006r65","unstructured":"Alternative Lifestyle Interventions for Vulnerable Ethnic Groups (ALIVE). ClinicalTrials.gov identifier: NCT04406792. Updated September 22, 2021. Accessed April 15, 2021. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04406792"},{"key":"hrv210006r66","unstructured":"A pragmatic approach to lowering the risk of diabetes mellitus after a diagnosis of gestational diabetes mellitus. ClinicalTrials.gov identifier: NCT04615351. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04615351"},{"key":"hrv210006r67","unstructured":"Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes (EMPA post-GDM). ClinicalTrials.gov identifier: NCT03215069. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03215069"},{"key":"hrv210006r68","unstructured":"The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous pregnancy-induced diabetes. ClinicalTrials.gov identifier: NCT01795248. Updated November 4, 2020. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01795248"},{"key":"hrv210006r69","unstructured":"Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC). ClinicalTrials.gov identifier: NCT04243278. Updated September 21, 2020. Accessed April 15, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04243278"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2785585\/jamacardiology_jowell_2021_rv_210006_1686580482.10437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T15:02:31Z","timestamp":1686754951000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2785585"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.4391","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}